Structures by: Drebushchak V. A.
Total: 21
Metacetamol, 3-Acetamidophenol
C8H9NO2
CrystEngComm (2015) 17, 32 6183
a=7.6202(8)Å b=19.010(3)Å c=10.1116(8)Å
α=90° β=90.388(8)° γ=90°
Tolbutamide form I^H^
C12H18N2O3S
CrystEngComm (2016) 18, 30 5736
a=20.7500(15)Å b=7.9160(7)Å c=9.0580(5)Å
α=90° β=90° γ=90°
Tolbutamide form I^L^
C12H18N2O3S
CrystEngComm (2016) 18, 30 5736
a=20.2133(6)Å b=7.8233(2)Å c=9.0717(2)Å
α=90° β=90° γ=90°
Tolbutamide form I^L^
C12H18N2O3S
CrystEngComm (2016) 18, 30 5736
a=19.7525(3)Å b=7.7998(1)Å c=9.0583(1)Å
α=90° β=90° γ=90°
Tolbutamide form I^L^
C12H18N2O3S
CrystEngComm (2016) 18, 30 5736
a=19.4331(3)Å b=7.8010(1)Å c=9.0277(1)Å
α=90° β=90° γ=90°
Tolbutamide form II
C12H18N2O3S
CrystEngComm (2016) 18, 30 5736
a=9.0256(2)Å b=17.1443(5)Å c=17.7904(5)Å
α=90° β=94.268(3)° γ=90°
C14H18N4O2,C42H42N28O14,Cl,(H2O)18.15
C14H18N4O2,C42H42N28O14,Cl,(H2O)18.15
CrystEngComm (2011) 13, 9 3241
a=15.4845(4)Å b=20.3081(6)Å c=27.1300(8)Å
α=90.00° β=98.873(2)° γ=90.00°
Chlorpropamide, β^II^-form
C10H13ClN2O3S
Acta Crystallographica Section B (2011) 67, 2 163-176
a=14.5882(5)Å b=9.2584(2)Å c=19.1532(6)Å
α=90.00° β=93.260(3)° γ=90.00°
Chlorpropamide, β^III^-form
C10H13ClN2O3S
Acta Crystallographica Section B (2011) 67, 2 163-176
a=28.4475(12)Å b=9.2322(3)Å c=19.2298(7)Å
α=90.00° β=95.562(4)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9022(7)Å b=20.901(3)Å c=10.2730(15)Å
α=90.00° β=114.600(10)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9110(7)Å b=20.922(3)Å c=10.2744(15)Å
α=90.00° β=114.586(10)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8960(6)Å b=20.878(2)Å c=10.2701(13)Å
α=90.00° β=114.634(9)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9098(7)Å b=20.194(3)Å c=10.1777(15)Å
α=85.571(13)° β=113.118(10)° γ=88.306(12)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8888(6)Å b=20.859(2)Å c=10.2664(13)Å
α=90.00° β=114.648(9)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9155(7)Å b=20.215(3)Å c=10.1862(16)Å
α=85.578(14)° β=113.133(11)° γ=88.301(13)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9021(7)Å b=20.167(3)Å c=10.1686(15)Å
α=85.540(11)° β=113.122(10)° γ=88.270(11)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8884(7)Å b=20.136(3)Å c=10.1518(15)Å
α=85.486(13)° β=113.065(10)° γ=88.263(12)°
Furosemide tetrahydrofuran solvate
C12H11Cl1N2O5S1,C4H8O1
Crystal Growth & Design (2014) 14, 2 513
a=10.9529(5)Å b=8.3816(3)Å c=20.0071(9)Å
α=90.00° β=95.024(4)° γ=90.00°
Furosemide N,N-dimethylformamide solvate
C12H11Cl1N2O5S1,C3H7N1O1
Crystal Growth & Design (2014) 14, 2 513
a=12.1430(5)Å b=12.4050(4)Å c=24.3562(11)Å
α=90.00° β=99.520(3)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8952(6)Å b=20.151(3)Å c=10.1585(13)Å
α=85.518(11)° β=113.088(9)° γ=88.264(11)°
Furosemide 1,4-dioxane solvate
C12H11Cl1N2O5S1,C4H8O2
Crystal Growth & Design (2014) 14, 2 513
a=7.9759(5)Å b=10.6923(7)Å c=10.9369(7)Å
α=86.247(5)° β=79.053(5)° γ=80.548(5)°